Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.10 Analyst target: $12.00 Upside: 990.91%
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the United States and internationally. The company is headquartered in Woodstock, Georgia.
See the full interactive analysis & chart →Informational only — not investment advice.